How a Copenhagen housing project by a $23 billion Novo-backed firm is rethinking big-city challenges like loneliness and access to sunlight
If you want to address civilization and society's issues, then you have to do it with the city," Urban Partners' co-CEO Claus ...
pharmaphorum2d
Novo completes $16.5bn takeover of Catalent
Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.
PE Hub6d
Novo Holdings, TA Associates agree Biocomposites investment
Novo Holdings and TA Associates have agreed to make an investment into Biocomposites.
pharmaphorum2mon
Novo Holdings leads $100m round for novel painkiller biotech
The Series C – which was led by Novo Nordisk's parent company Novo Holdings – follows a $15 million second round for the South San Francisco-based company in 2017 and a $15 million Series A in ...
Finanznachrichten6d
Biocomposites; Novo Holdings; TA Associates: Novo Holdings and TA Associates partner with Biocomposites to drive next chapter of its growth
As part of the transaction TA, Biocomposites' majority shareholder since 2017, will reinvest in the Company alongside new investor Novo Holdings and Biocomposites' management. The transaction ...
PR Newswire1mon
Novo Holdings invests in $200M Series A for Windward Bio launch to advance long-acting treatments for asthma and COPD
COPENHAGEN, Denmark, Jan. 10, 2025 /PRNewswire/ -- Novo Holdings, a leading life science investor, today announced that it has invested in a $200M Series A launch financing for Windward Bio.
akm3mon
Danish Novo Holdings has received EU approval to acquire Catalent for $16.5 billion
Danish Novo Holdings has received approval from the European Union to acquire Catalent Inc., one of the world's largest pharmaceutical companies. This is reported in the press release of the European ...